Investigating Incubators & Innovation with Mason Ailstock

Video

Mason Ailstock, CEO of the Rowen Foundation, discusses incubators and their potential to promote innovation.

In this video interview, Mason Ailstock, CEO of the Rowen Foundation, talked to Grant Playter, associate editor, on the topic of incubators and their potential to promote innovation.

Rowen is a knowledge community in Metro Atlanta focused on fostering collaboration across industries, including those in the medical, environmental, and agricultural fields. In this interview, Mason touches on the current status of the Rowen Foundation, the importance of fostering collaboration in this manner, and how it can promote innovation in the biopharma industry.

Recent Videos
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Related Content
Blue Paper Boat Leading A Fleet Of Small White Boats With Compass Icon On Grey Concrete - Leadership Concept | Image Credit: ©Philip Steury -stock.adobe.com

Navigating the Complexities of Emerging Therapy Development

Cynthia A. Challener
April 8th 2025
Article

Advancement of emerging therapies faces hurdles across all aspects and phases of drug development and manufacturing.

Drug Solutions Podcast: Examining the State of Biopharma Investment

Drug Solutions Podcast: Examining the State of Biopharma Investment

Grant Playter
June 6th 2023
Podcast

In this episode, Siegfried Schmitt, vice president, Technical at Parexel, discusses the state of biopharma investment in 2023.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Novartis’ Steady Investments in Slovenia Result in New Viral Vector Manufacturing Facility and a Growing Work Force

Feliza Mirasol
March 27th 2025
Article

With a completed €40 million (US$43 million) investment in Slovenia, Novartis has opened its first specialized viral vector production facility in Europe, following earlier significant investments in R&D that has led to the growth of Slovenia’s workforce.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

AstraZeneca and Alteogen Sign License Agreement for Developing Subcutaneous Formulations of Oncology Assets

Feliza Mirasol
March 25th 2025
Article

Under the agreement, AstraZeneca will use Alteogen’s proprietary hyaluronidase platform technology to develop and commercialize subcutaneous formulations of multiple oncology assets in its portfolio.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Latigo Biotherapeutics Raises $150 Million to Advance Non-Opioid Pain Therapeutics

Feliza Mirasol
March 24th 2025
Article

With financing led by Blue Owl Capital, Latigo will use the funds to further develop non-opioid pain treatments as well as develop other candidates in its pipeline.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Shilpa Biologicals and mAbTree Biologics to Collaborate on Novel Immuno-Oncology Asset

Feliza Mirasol
March 18th 2025
Article

The partnership aims to develop and commercialize a novel checkpoint inhibitor for immuno-oncology applications.